Christopher W. Nixon

Christopher W. Nixon

(403) 266-9017
(403) 266-9034
888 3rd St SW, Suite 4200, Banker's Hall W, Calgary, AB
Year called to bar: 1980 (AB)
Christopher Nixon is counsel in the capital markets and mergers and acquisitions groups. His practice focuses on business law, with an emphasis on mergers and acquisitions, corporate finance, joint ventures, private equity, corporate and trust reorganizations, and corporate governance. His practice involves both transactional and advisory assignments, representing, among others, oil and gas exploration entities, oilfield service entities, investment funds, and investment dealers in Canada, the US, Europe, and Asia.
Christopher W. Nixon is a featured Leading Lawyer in:
Canadian Legal Lexpert Directory
Consistently Recommended
Canadian Legal Lexpert Directory
Consistently Recommended
Canadian Legal Lexpert Directory
Most Frequently Recommended
Canadian Legal Lexpert Directory
Consistently Recommended
Canadian Legal Lexpert Directory
Consistently Recommended
Canadian Legal Lexpert Directory
Most Frequently Recommended
Read more about Christopher W. Nixon in ...
On December 29, 2019, CPF Canada Holdings Corp. (“CPF”), a subsidiary of Charoen Pokphand Foods Pcl, Thailand’s largest agriculture conglomerate, acquired all of the shares of HyLife Investments Ltd. (“HIL”) for CAD$498,000,000.
AltaGas Canada Inc. (“ACI”) completed its offering of $250 million of senior unsecured medium-term notes, series 2 (the “Offering”) having a fixed coupon rate of 3.15% per annum, paid semi-annually and maturing on April 6, 2026.
Pembina Pipeline Corporation completed its offering of $800 million of senior unsecured medium-term notes (the “Offering”).
On October 25, 2018, AltaGas Canada Inc. (“ACI”) completed an initial public offering of its common shares. In connection with the initial public offering, ACI issued 16.5 million common shares at a price per share of $14.50 for gross proceeds of approximately $239 million, and the common shares began trading on the Toronto Stock Exchange under the symbol “ACI.”
On June 22, 2018, Axium Infrastructure (Axium) and Manulife Financial Corporation (Manulife), through a special-purpose acquisition vehicle Northwestern Hydro Acquisition Co Inc., completed their acquisition of a 35% indirect equity interest in the Northwest British Columbia Hydroelectric Facilities (the Facilities) from AltaGas Ltd. (AltaGas).
On April 20, 2016, Paramount Resources (Paramount) completed the sale of sour gas processing assets in north western Alberta to Pembina Gas Services Limited Partnership, an indirect wholly owned subsidiary of Pembina Pipeline Corporation (Pembina) for cash and other considerations.
On January 13, 2016, Gran Tierra Energy Inc. (Gran Tierra) completed the acquisition of all of the issued and outstanding common shares of Petroamerica Oil Corp. (Petroamerica), valued at $136,835,985, by way of plan of arrangement under the provisions of the Business Corporations Act (Alberta). The acquisition is a first step in Gran Tierra’s strategy to grow and diversify its portfolio throughout the productive basins in Colombia.
On June 30, 2015, Crescent Point Energy Corp. (Crescent Point), one of Canada’s largest light and medium oil producers, acquired all of the issued and outstanding common shares of Legacy Oil + Gas Inc. by way of arrangement (the Legacy Acquisition). The total consideration for the Legacy Acquisition was approximately $1.53 billion, comprising approximately 18.97 million Crescent Point common shares and the assumption of approximately $967 million of net debt.
Athabasca Oil Corporation completed the sale of its 40 per cent interest in the Dover oil sands project to Phoenix Energy Holdings Limited, a wholly owned subsidiary of PetroChina International Investment Limited for approximately $1.184 billion. Athabasca is a Canadian energy company with a diverse portfolio of thermal and light oil assets primarily situated in Alberta's Western Canadian Sedimentary Basin.
Glencore plc acquired Calgary-based Caracal Energy Inc. through a wholly owned subsidiary by way of a plan of arrangement for an all cash consideration of approximately $1.48 billion.
On July 13, 2001, KS Biomedix Plc of the United Kingdom completed the purchase of all of the outstanding shares of Avicenna Medica Inc. of Edmonton, Alberta for a total purchase price of $90 million.